Title

Chlorhexidine for Prevention of Catheter-Associated Urinary Tract Infections: The Totality of Evidence - Author's Reply

Authors

Brett G. Mitchell, Avondale University CollegeFollow
Allen Cheng, Monash UniversityFollow
Oyebola Fasugba, Australian Catholic University
Anne Gardner, Australian Catholic UniversityFollow
Nicholas Graves, Queensland University of TechnologyFollow
Jane Koerner, Australian Catholic UniversityFollow
Peter Collignon, Australian National UniversityFollow

Author Faculty (Discipline)

Nursing

Document Type

Response or Comment

Publication Date

8-2019

Early Online Version

7-24-2019

JOURNAL

The Lancet Infectious Diseases

VOLUME NUMBER

19

ISSUE NUMBER

8

PAGE NUMBERS

808-809

ISSN

1473-3099

Embargo Period

3-19-2020

ANZSRC / FoR Code

060502 Infectious Agents| 1199 OTHER MEDICAL AND HEALTH SCIENCES| 111716 Preventive Medicine

Avondale Research Centre

Lifestyle and Health Research Centre

Reportable Items (HERDC/ERA)

C2

Link to publisher version (DOI)

https://doi.org/10.1016/S1473-3099(19)30349-4

Comments

Due to copyright restrictions this article is unavailable for download.

© 2019 Elsevier Ltd. All rights reserved.

Recommended Citation

Mitchell, B. G., Cheng, A. C., Fasugba, O., Gardner, A., Graves, N., Koerner, J., & Collignon, P. (2019). Chlorhexidine for prevention of catheter-associated urinary tract infections: The totality of evidence-Author's reply [Correspondence]. The Lancet Infectious Diseases, 19(8), 808-809. doi:10.1016/S1473-3099(19)30349-4